Lawsuits Likely to Follow ‘Superbug’ Scare

By BRIAN MELLEY | February 23, 2015

  • February 23, 2015 at 3:13 pm
    Barbara J. Brasher RN, CLNC says:
    Like or Dislike:
    Thumb up 0
    Thumb down 0

    You are so correct. I have spend much time trying to get an attorney to go the long haul in proving that hospitals and some of their unmanaged staff are the cause for patient hospital complications.

    It is only a matter of time before the hospital and their corporate owner will be held accountable for Hospital Acquired Infections (HAI).

    If you are looking for a bulldog I am that person that will prove causation.

    Barbara

  • February 25, 2015 at 5:11 pm
    Carol Johns, MSN, RN, CNE says:
    Like or Dislike:
    Thumb up 0
    Thumb down 0

    I doubt this will be so difficult to prove, as Muscarella claims, because there aren’t that many people who come into the hospital already colonized with carbapenem-resistant Enterobacteriaceae (CRE). I’ve been concerned about sterilization techniques for endoscopic equipment for several years.
    However, another problem might be proving that CRE caused death – depending on why the procedures were being done in the first place. Many bile duct and pancreatic conditions are already high risk. I would love to work on a class action suit in this matter.

  • February 25, 2015 at 5:20 pm
    Carol Johns, MSN, RN, CNE says:
    Like or Dislike:
    Thumb up 0
    Thumb down 0

    I suggest that it will not be difficult to make the link between endoscope and infection, despite what Muscarella says, because most people are not already colonized with CRE. What may be more difficult is proving that the infection caused death. Many patients undergoing endoscopies for bile duct and pancreatic conditions are already high risk.
    There is much to be discovered about the sterilization practices at the hospital, the continuing education of the people responsible for sterilizing the equipment, and the manufacturer’s training when the scopes were sold to the hospital. Reviewing FDA reports of other incidences of contamination will add another layer of discovery. Company memos as reports of contamination were received will be revealing.
    I would love to work on these cases.



Add a Comment

Your email address will not be published. Required fields are marked *

*